After cataract surgery, the intravitreal anti-VEGF injection was administered to 1180 (0.7%) operated eyes, of which 191 eyes were diagnosed with diabetic macular edema (DME) and 989 eyes with CME. This evidence concerns the gene VEGFA and diabetic macular edema.